The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This…
Latest
-
-
The holiday season brings more than festive cheer, as for investors, it may signal the start of the so-called Santa Claus rally.…
-
Craig Hemke, publisher of TFMetalsReport.com, shares his thoughts on the gold and silver markets heading into 2026, outlining why he remains bullish.…
-
Altius Minerals (TSX:ALS,OTCQX:ATUSF) is making a bet on a lithium market recovery, agreeing to acquire Lithium Royalty (TSX:LIRC) in a C$520 million…
-
Politics
Epstein file drop includes ‘untrue and sensationalist claims’ about Trump, DOJ says
by adminThe Department of Justice warned Tuesday that some documents in the latest batch of files it published related to Jeffrey Epstein included…
-
Politics
Lawmakers probe SBA loans linked to Minnesota’s $9B fraud scandal: ‘Reckless decision making’
by adminThe House Small Business Committee sent a letter this week to the Small Business Administration demanding answers on federal pandemic relief funds…
-
Obamacare subsidies that have dominated the conversation on Capitol Hill are set to expire after Congress failed to act, but a cohort…
-
Politics
Trump promises cheaper drugs under TrumpRx, but economists say the long-term costs may be hidden
by adminAs President Donald Trump rolls out his TrumpRx proposal to cut prescription drug prices, economists are raising questions about what happens when…